Humulin 70/30 is a Subcutaneous Injection, Suspension in the Human Otc Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Insulin Human.
| Product ID | 50090-0444_6576ec56-9574-47a0-a784-82cad20091b0 |
| NDC | 50090-0444 |
| Product Type | Human Otc Drug |
| Proprietary Name | Humulin 70/30 |
| Generic Name | Insulin Human |
| Dosage Form | Injection, Suspension |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 1989-06-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019717 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | INSULIN HUMAN |
| Active Ingredient Strength | 100 [iU]/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2014-11-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019717 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2014-11-28 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| INSULIN HUMAN | 100 [iU]/mL |
| SPL SET ID: | 7f6328dc-2270-4cbd-bcb2-fb0f32a1e872 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50090-0444 | Humulin 70/30 | Humulin 70/30 |
| 47918-874 | Afrezza | Insulin Human |
| 0002-8215 | Humulin | Insulin human |
| 0002-8315 | Humulin | Insulin human |
| 0002-8501 | Humulin | Insulin human |
| 0002-8715 | Humulin | Insulin human |
| 0002-8803 | Humulin | Insulin human |
| 0002-8805 | Humulin | Insulin human |
| 0002-8824 | Humulin | Insulin human |
| 0338-0126 | MYXREDLIN | insulin human |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() HUMULIN 75773392 2345798 Live/Registered |
Eli Lilly and Company 1999-08-11 |
![]() HUMULIN 75253619 not registered Dead/Abandoned |
Eli Lilly and Company 1997-03-07 |
![]() HUMULIN 73303147 1201754 Live/Registered |
Eli Lilly and Company 1981-03-27 |